Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery (Q24236309)

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

Cost-effectiveness of oral anticoagulants versus aspirin in patients after infrainguinal bypass grafting surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

Outcome after occlusion of infrainguinal bypasses in the Dutch BOA Study: comparison of amputation rate in venous and prosthetic grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

Effects of three months of low molecular weight heparin (dalteparin) treatment after bypass surgery for lower limb ischemia--a randomised placebo-controlled double blind multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

The effect of anticoagulation therapy and graft selection on the ischemic consequences of femoropopliteal bypass graft occlusion: results from a multicenter randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

Can screening for genetic markers improve peripheral artery bypass patency?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

A decade of oral anticoagulant treatment to maintain autologous vein grafts for femoropopliteal atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

Low molecular weight heparin (enoxaparin) versus dextran in the prevention of early occlusion following arterial bypass surgery distal to the groin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

Can low molecular weight heparin replace unfractionated heparin during peripheral arterial reconstruction? An open label prospective randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

Long-term arterial-graft patency in relation to platelet adhesiveness, biochemical factors, and anticoagulant therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

Low-molecular-weight heparin in arterial reconstructive surgery: a double-blind, randomized dose-finding trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

Perioperative low molecular weight heparin for infrageniculate bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

Hypercoagulable abnormalities and postoperative failure of arterial reconstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

Graft type for femoro-popliteal bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

Antiplatelet therapy and other interventions after revascularisation procedures in patients with peripheral arterial disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

Vascular graft thrombus formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

Oral anticoagulation in peripheral vascular surgery: how intense, for how long, or at all?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

Pharmacological prophylaxis against postoperative graft occlusion after peripheral vascular surgery: a world-wide survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

Adaptive changes in autogenous vein grafts for arterial reconstruction: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

Long-term outcome after early infrainguinal graft failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

The mechanical properties of infrainguinal vascular bypass grafts: their role in influencing patency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

Role of endothelial cell denudation and smooth muscle cell dedifferentiation in neointimal formation of human vein grafts after coronary artery bypass grafting: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

Systematic review of randomized controlled trials of aspirin and oral anticoagulants in the prevention of graft occlusion and ischemic events after infrainguinal bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

Adjuvant medical therapy in peripheral bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

Clinical, biochemical, and rheologic factors affecting the outcome of infrainguinal bypass grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

Ancrod versus heparin for anticoagulation during vascular surgical procedures

21 January 2018

1 reference

12 December 2020

Arterial repair of the lower limbs: prevention of prosthetic grafts occlusion by LMW-heparin.

1 reference

12 December 2020

Low-molecular-weight heparin vs. unfractionated heparin in femorodistal reconstructive surgery: a multicenter open randomized study. Enoxart Study Group

1 reference

12 December 2020

Surgical treatment of peripheral circulation disorders

1 reference

12 December 2020

[Interventions in infrainguinal bypass grafts]

1 reference

12 December 2020

Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial

1 reference

12 December 2020

Pathobiology of intimal hyperplasia

1 reference

12 December 2020

Optimal oral anticoagulant intensity to prevent secondary ischemic and hemorrhagic events in patients after infrainguinal bypass graft surgery. Dutch BOA Study Group

1 reference

12 December 2020

Low-molecular weight heparin versus dextran in the prevention of early occlusion following arterial bypass surgery distal to the groin

1 reference

12 December 2020

Immediate occlusion of in situ saphenous vein bypass grafts: a survey of 329 reconstructions

1 reference

12 December 2020

Vein interposition cuffs decrease the intimal hyperplastic response of polytetrafluoroethylene bypass grafts

1 reference

12 December 2020

Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery

1 reference

12 December 2020

Polytetrafluoroethylene bypasses to infrapopliteal arteries without cuffs or patches: a better option than amputation in patients without autologous vein

1 reference

12 December 2020

Enhancement of tissue factor expression by vein segments exposed to coronary arterial hemodynamics

1 reference

12 December 2020

[Experiences with adjuvant prostaglandin therapy in vascular surgery interventions]

1 reference

12 December 2020

Prosthetic above-knee femoropopliteal bypass grafting: results of a multicenter randomized prospective trial. Above-Knee Femoropopliteal Study Group

1 reference

12 December 2020

Prostaglandin E1 as an adjuvant therapy in the event of femoropopliteal and crural great saphenous vein in situ bypass surgery

1 reference

12 December 2020

Technical defects as a cause of early graft failure after femorodistal bypass

1 reference

12 December 2020

Costs of outpatient anticoagulant treatment in patients with cerebral and peripheral arterial occlusive disease

1 reference

12 December 2020

Vein bypass surgery for femoro-popliteal arteriosclerosis: influence of different risk factors on patient survival and the importance of anticoagulant treatment

1 reference

12 December 2020

The influence of anticoagulant treatment on the probability of function in femoropopliteal vein bypass surgery: analysis of a clinical series (1970 to 1985) and interim evaluation of a controlled clinical trial

1 reference

12 December 2020

Influence of coumarin treatment on patency and limb salvage after peripheral arterial reconstructive surgery

1 reference

12 December 2020

Early adaptation of human lower extremity vein grafts: wall stiffness changes accompany geometric remodeling

1 reference

12 December 2020

[Late results of anticoagulation in reconstructions for occlusive disease of the lower extremity]

1 reference

12 December 2020

[Supragenicular bypass: venous in comparison with synthetic prosthesis (PTFE)]

1 reference

12 December 2020

Low molecular mass heparin instead of unfractionated heparin during infrainguinal bypass surgery

1 reference

12 December 2020

Comparison of cilostazol with warfarin as antithrombotic therapy after femoro-popliteal bypass surgery using an ePTFE graft

1 reference

12 December 2020

The effects of aspirin, dipyridamole and warfarin in femorodistal reconstruction: long-term results

1 reference

12 December 2020

Modulation of tissue factor protein expression in experimental venous bypass grafts

1 reference

12 December 2020

Effect of antiplatelet and anticoagulant therapy on patency of femorotibial bypass grafts

1 reference

12 December 2020

Peroperative anticoagulation with antithrombin or heparin in infrainguinal bypass surgery

1 reference

12 December 2020

Pharmacologic intervention to prevent graft failure.

1 reference

12 December 2020

Hemorrhagic complications during long-term postoperative warfarin administration in patients undergoing lower extremity arterial bypass surgery

1 reference

12 December 2020

Durability of the in situ saphenous vein arterial bypass: a comparison of primary and secondary patency

1 reference

12 December 2020

Cochrane Database of Systematic Reviews

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000536.PUB2

7 January 2021